Tesar Lab awarded new grant from NINDS to advance novel therapeutics for multiple sclerosis

The Tesar Lab was recently awarded a grant from the National Institute of Neurological Disorders and Stroke to advance therapeutics for multiple sclerosis. The Tesar Lab's expertise in stem cell biology and high throughput screening provides a unique opportunity to discover innovative therapeutics that could halt devastating diseases.

News Category: